Pharmaceutical firm Cadila Healthcare today announced that it has received USFDA approval to conduct clinical trials for ZYGK1, a new molecular entity (NME), for treating diabetes. Cadila Healthcare said the new molecular entity (NME) being designed and developed at the company’s research centre, is a potent and orally administered small molecule glucokinase activator. The...
Jubilant Life Sciences (JLS) on Tuesday said it is setting up a manufacturing plant to produce Symtet, a key ingredient for making insecticide ‘Chlorpyrifos’, at Bharuch in Gujarat, as part of its nearly Rs 350 crore capacity expansion plans for the next fiscal. JLS will set up a manufacturing plant in the Special Economic...
Jordan-based Hikma Pharmaceuticals is planning to buy 30% stake in Mumbai-based API maufacturing firm Unimark Remedies Limited according to DealCurry report. Unimark has two active pharmaceutical ingredient (API) plants at Vapi and Bavla, in Gujarat, both USFDA approved, and a third one in Khopoli, Maharashtra. The total investment on the units is approximately $66...
The Government of Gujarat in association with the Association of Biotechnology Led Enterprises (ABLE) and Gujarat State Biotechnology Mission (GSBTM) today organized the 6th edition of BioInvest 2010 in Ahmedabad. With the support of the Industrial Extension Bureau (iNDEXTb), the summit brought together relevant government agencies, biotech and life science companies, institutional investors, investment...
Multinational FMCG giant Reckitt Benckiser today said it has agreed to fully acquire Ahmedabad -based Paras Pharmaceuticals Ltd for Rs. 3,260 crore. As part of the deal, the company will buy the 63 per cent stake of emerging markets private equity investor Actis, along those of Sequoia Capital and the remaining shareholders, including Paras...
Kendle India, a subsidiary of US based Kendle group, a fifth largest global clinical research organization (CRO) with about $ 415 million net revenues in 2009, has become the first company to start its operation in Mindspace, Gujarat’s first special economic zone for IT/ITES, developed by Mumbai-based K Raheja Corp on Ahmedabad-Gandhinagar Knowledge Corridor....
By Japan K Pathak Do you know ? Suzlon’s Tulsi Tanti is world’s third-largest wind turbine supplier but Suzlon Energy was his 17th venture in life. Or do you know, Baba Kalyani, the Chairman and Managing Director of Bharat Forge contributes a part in every second truck in the US? You can have plenty...
The prestigious ‘61st Indian Pharmaceutical Congress’ (IPC 2009) will commence in Ahmedabad from Friday, December 11, 2009 at the Nirma University, Ahmedabad. The mega event has attracted interest of the stakeholders in such a way that for the first time in the history of the industry, live web-casting of the inaugural session and other...
Ahmedabad based pharma major Torrent Pharmaceuticals on Saturday commissioned a new $ 11 million(Rs 51 crore) human insulin manufacture facility exclusively for global healthcare major Novo Nordisk. The new unit situated at Torrent Pharma’s existing facility at Kadi, is an integrated manufacturing and vial packaging plant with a capacity to manufacture 26 million vials...
The government of India is planning to set up a dedicated zone for medical devices manufacturing and the first medical devices and equipment park would come up in India’s western state of Gujarat. “We are taking a cluster approach for developing the medical device sector in the country and first such medical device park...
After prolong interval of 23 years Gujarat will host Indian Pharmaceutical Congress(IPC) at Ahmedabad on 11-12-13 December this year. Gujarat Health Minister Jaynagaryan Vyas on Saturday launched a website www.ipc2009.co.in for online registration of delegates and exhibitors. Minister Vyas also released a souvenir of 61st IPC. downloads psych:9 “Gujarat produces one third of total...
Ahmedabad-based Paras Pharmaceuticals has launched two products Moov-Neck & Shoulder and D’Cold Natural. The company plans to achieve annual growth of 25 per cent. “Moov has reported total sales of around Rs 80 crore per annum and with the launch of the new variant, we are expecting Rs 100 crore sales from the brand...